|
WO2021075928A1
|
|
Composition for enhancing or improving immune system comprising bifidobacterium bifidum
|
|
KR102040117B1
|
|
Bifidobacterium bifidum MG731 and composition for preventing or treating cancers comprising the same
|
|
EP3805258A1
|
|
Pharmaceutical composition for preventing or treating cancer, containing cd300e inhibitor as active ingredient
|
|
WO2020040408A1
|
|
Novel cutibacterium granulosum strain, and composition comprising such strain or culture thereof for preventing or treating acne
|
|
WO2020040407A1
|
|
Novel cutibacterium avidum strain, and composition for preventing or treating atopic dermatitis, comprising strain or cultured product thereof
|
|
WO2019221516A1
|
|
Pharmaceutical composition for preventing or treating cancer comprising lrit2 inhibitor as active ingredient
|
|
EP3775889A1
|
|
Novel target for anti-cancer and immune-enhancing
|
|
CN110468061A
|
|
The novel strain for having the effect of prevention or treating cancer
|
|
EP3737945A1
|
|
Novel use of kirrel2 and kirrel2 inhibitor
|
|
US2021106630A1
|
|
Lactobacillus Rhamnosus LM1019 Strain And Composition For Preventing And Treating Obesity Or Diabetes Mellitus Comprising Same
|
|
KR20190136389A
|
|
Immune modulator comprising cd300lg and fragment thereof as effective ingredient
|
|
KR101980525B1
|
|
Lactococcus lactis GEN3013 and composition for preventing or treating cancers comprising the same
|
|
KR101980527B1
|
|
Lactobacillus fermentum LM1016 and composition for preventing and treating cardiovascular diseases comprising the same
|
